AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27412415 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG revaccination
Number of subjects: 72
Study 27412415 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 72
Study 24903113 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain coping skills training program delivered by trained physical therapists
Number of subjects: 222
Study 22826368 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained teachers using language modification techniques
Number of subjects: 43
Study 22826368 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained students with language impairment
Number of subjects: 43
Study 22826368 — intervention group
Group type: COMPARATOR
Intervention: Control group of untrained teachers
Number of subjects: 43
Study 22826368 — intervention group
Group type: COMPARATOR
Intervention: Control group of students with language impairment
Number of subjects: 43
Study 21076381 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept (more intensive regimen)
Number of subjects: 1209
Study 21076381 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept (less intensive regimen)
Number of subjects: 1209
Study 21076381 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine A (CsA)
Number of subjects: 1209
Study 21076381 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept
Number of subjects: 1209
Study 18718427 — intervention group
Group type: EXPERIMENTAL
Intervention: PISA-velocity-time integral (VTI)
Number of subjects: 73
Study 18718427 — intervention group
Group type: EXPERIMENTAL
Intervention: simplified PISA
Number of subjects: 73
Study 18718427 — intervention group
Group type: EXPERIMENTAL
Intervention: M-mode PISA
Number of subjects: 73
Study 18718427 — intervention group
Group type: EXPERIMENTAL
Intervention: serial PISA
Number of subjects: 73
Study 16048149 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulas supplemented with both n-3 and n-6 LCPUFA
Number of subjects: 0
Study 16048149 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulas with n-3 LCPUFA for preterm infants
Number of subjects: 0
Study 16048149 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding n-3 LCPUFA to preterm infants
Number of subjects: 0
Study 16048149 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulas providing both n-3 and n-6 LCPUFA
Number of subjects: 0
Study 16048149 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding more than 0.2% DHA and 0.3% AA
Number of subjects: 0
Study 16048149 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term feeding study of preterm infants
Number of subjects: 0
Study 16048149 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA intake in the range provided by human milk
Number of subjects: 0
Study 14528526 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body training program
Number of subjects: 128
Study 14528526 — intervention group
Group type: COMPARATOR
Intervention: Education support group (control)
Number of subjects: 128
Study 10999678 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA ligation under fentanyl anesthesia (15 microg/kg)
Number of subjects: 7
Study 8867680 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory biofeedback training (visual training)
Number of subjects: 55
Study 8867680 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 55
Study 1512330 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (rt-PA)
Number of subjects: 1786
Study 6147551 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc acetate 600 mg a day for 7 days
Number of subjects: 22
Study 6147551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 30860003 — intervention group
Group type: EXPERIMENTAL
Intervention: Noom Coach for Bariatric Health
Number of subjects: 40
Study 30860003 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 40
Study 30113122 — intervention group
Group type: COMPARATOR
Intervention: Exercise only group
Number of subjects: 81
Study 30113122 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and protein supplementation group
Number of subjects: 81
Study 26748391 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise program + placebo
Number of subjects: 407
Study 26748391 — intervention group
Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 407
Study 26748391 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine sulphate
Number of subjects: 407
Study 26748391 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise program + glucosamine sulphate
Number of subjects: 407
Study 24672331 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard combined group (S‐C group)
Number of subjects: 208
Study 24672331 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive combined group (I‐C group)
Number of subjects: 208
Study 24672331 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive atorvastatin group (I‐A group)
Number of subjects: 208
Study 23290037 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxithromycin disperse tablet 0.15 g every day and ambroxol hydrochloride tablet 90 mg 3 times a day
Number of subjects: 50
Study 23290037 — intervention group
Group type: COMPARATOR
Intervention: Ambroxol hydrochloride tablet 90 mg 3 times a day
Number of subjects: 50
Study 20117105 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-captopril active renin concentration (ARC)
Number of subjects: 114
Study 20117105 — intervention group
Group type: COMPARATOR
Intervention: Post-captopril plasma renin activity (PRA)
Number of subjects: 114
Study 20103914 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise with vascular occlusion (LIO)
Number of subjects: 51
Study 20103914 — intervention group
Group type: COMPARATOR
Intervention: Dynamic balance exercise (DBE)
Number of subjects: 51
Study 15692221 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg b.i.d. for 4 days
Number of subjects: 13
Study 15692221 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 80 mg b.i.d. for 4 days
Number of subjects: 13
Study 15692221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 11823660 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional MRI (fMRI) during a hand-tapping task in CADASIL patients
Number of subjects: 16
Study 11823660 — intervention group
Group type: COMPARATOR
Intervention: Functional MRI (fMRI) during a hand-tapping task in healthy controls
Number of subjects: 16
Study 10423311 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin high dose (6 g/100 mL over 2 hr, three times a day)
Number of subjects: 13
Study 10423311 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin regular dose (6 g/300 mL over 18 hr/day)
Number of subjects: 13
Study 7557855 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa 3 mIU three times weekly for 6 months
Number of subjects: 46
Study 7557855 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 46
Study 2164528 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (E) 10 mg orally
Number of subjects: 8
Study 2164528 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 8
Study 731808 — intervention group
Group type: EXPERIMENTAL
Intervention: Vesical neck closure
Number of subjects: 102
Study 731808 — intervention group
Group type: COMPARATOR
Intervention: Balloon catheter
Number of subjects: 102
Study 30738995 — intervention group
Group type: EXPERIMENTAL
Intervention: QuantiFERON-TB Gold In-Tube (QFT) testing
Number of subjects: 20486
Study 30738995 — intervention group
Group type: COMPARATOR
Intervention: Moderate alcohol consumption (<10 g/day)
Number of subjects: 20486
Study 30738995 — intervention group
Group type: EXPERIMENTAL
Intervention: Indeterminate QFT result
Number of subjects: 20486
Study 28088839 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-648 (PDE4 inhibitor) at doses of 0.05-0.85 mg in healthy volunteers
Number of subjects: 0
Study 28088839 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-648 (PDE4 inhibitor) at a daily dose of 0.1 mg
Number of subjects: 0
Study 25636072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine (10 mg twice a day for 6 weeks)
Number of subjects: 33
Study 25636072 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice a day for 6 weeks)
Number of subjects: 33
Study 22257584 — intervention group
Group type: EXPERIMENTAL
Intervention: Online in-house information literacy tutorial
Number of subjects: 77
Study 22257584 — intervention group
Group type: COMPARATOR
Intervention: One hour face-to-face session
Number of subjects: 77
Study 21859992 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen with or without octreotide
Number of subjects: 621
Study 18469148 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microM ANG II
Number of subjects: 8
Study 18469148 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (2 microg/l)
Number of subjects: 8
Study 18469148 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitro-l-arginine (NLA)
Number of subjects: 8
Study 18469148 — intervention group
Group type: EXPERIMENTAL
Intervention: NLA + losartan
Number of subjects: 8
Study 18469148 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium ascorbate (10 mM)
Number of subjects: 8
Study 18469148 — intervention group
Group type: COMPARATOR
Intervention: Ringer solution
Number of subjects: 8
Study 16950434 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (SEPS combined with superficial vein ligation)
Number of subjects: 170
Study 16950434 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (ambulatory compression therapy)
Number of subjects: 170
Study 14501003 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal volume
Number of subjects: 0
Study 11053939 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI)
Number of subjects: 20
Study 11053939 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 9094730 — intervention group
Group type: EXPERIMENTAL
Intervention: Pari‐Baby nebulizer
Number of subjects: 20
Study 9094730 — intervention group
Group type: COMPARATOR
Intervention: Detergent‐coated Babyhaler
Number of subjects: 20
Study 9094730 — intervention group
Group type: COMPARATOR
Intervention: Nebuchamber
Number of subjects: 20
Study 7903976 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous regimen of zidovudine and didanosine
Number of subjects: 41
Study 7903976 — intervention group
Group type: COMPARATOR
Intervention: Alternating regimen of zidovudine and didanosine
Number of subjects: 41
Study 2498620 — intervention group
Group type: EXPERIMENTAL
Intervention: Kliogest (continuous treatment)
Number of subjects: 34
Study 2498620 — intervention group
Group type: COMPARATOR
Intervention: Trisequens (sequential treatment)
Number of subjects: 34
Study 1091856 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent intravenous injection of heparin
Number of subjects: 100
Study 1091856 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of heparin
Number of subjects: 100
Study 1091856 — intervention group
Group type: COMPARATOR
Intervention: Heparin with laboratory control (partial thromboplastin time)
Number of subjects: 100
Study 1091856 — intervention group
Group type: COMPARATOR
Intervention: Heparin without laboratory control
Number of subjects: 100
Study 31785505 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) with 100% oxygen during intubation
Number of subjects: 106
Study 31785505 — intervention group
Group type: COMPARATOR
Intervention: Bag-valve-mask ventilation for preoxygenation followed by intubation (Control)
Number of subjects: 106
Study 30889093 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of isoflavones (10mg, n = 35)
Number of subjects: 101
Study 30889093 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose of isoflavones (35mg, n = 37)
Number of subjects: 101
Study 30889093 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of isoflavones (60mg, n = 29)
Number of subjects: 101
Study 30889093 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sample (all doses)
Number of subjects: 101
Study 28817063 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy diet
Number of subjects: 0
Study 28817063 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat diet
Number of subjects: 0
Study 28817063 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0
Study 25953600 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel low energy-dense semi-solid food (0.72kcal/g)
Number of subjects: 68
Study 25953600 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher energy-dense semi-solid food (1.57kcal/g)
Number of subjects: 68
Study 25953600 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate version of the test food
Number of subjects: 68
Study 25953600 — intervention group
Group type: COMPARATOR
Intervention: Higher energy-dense meal in UK participants
Number of subjects: 68
Study 23688320 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving Bright, Eating Smart (physical activity and diet) programme
Number of subjects: 222
Study 23688320 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study 21552085 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (15 minutes of running/jogging)
Number of subjects: 0
Study 21552085 — intervention group
Group type: COMPARATOR
Intervention: Control condition (classroom task not preceded by exercise)
Number of subjects: 0
Study 19725237 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 19
Study 19725237 — intervention group
Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 19
Study 17024692 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg DiaPep277
Number of subjects: 48
Study 17024692 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg DiaPep277
Number of subjects: 48
Study 17024692 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg DiaPep277
Number of subjects: 48
Study 17024692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 15757154 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless pH-testing system
Number of subjects: 41
Study 15757154 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter‐based pH-testing
Number of subjects: 41
Study 11432478 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile pump flow (n = 11)
Number of subjects: 21
Study 11432478 — intervention group
Group type: COMPARATOR
Intervention: Laminar pump flow (n = 10)
Number of subjects: 21
Study 8931582 — intervention group
Group type: EXPERIMENTAL
Intervention: Imageable words
Number of subjects: 0
Study 8931582 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-imageable words
Number of subjects: 0
Study 8931582 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing semantic association within imageable and non-imageable groups
Number of subjects: 0
Study 8931582 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomly linked pairs
Number of subjects: 0
Study 8931582 — intervention group
Group type: EXPERIMENTAL
Intervention: Closely related pairs
Number of subjects: 0
Study 1362320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine alone (group I)
Number of subjects: 45
Study 1362320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine in combination with HBIG (group II)
Number of subjects: 45
Study 1362320 — intervention group
Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 45
Study 3932033 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of prednisone, azathioprine, cyclophosphamide, Heparoid Spofa forte ling., Heparin retard Spofa and dipyridamole
Number of subjects: 31
Study 3932033 — intervention group
Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 31
Study 31176057 — intervention group
Group type: EXPERIMENTAL
Intervention: Agency (measured using a theory-based measure composed of 23 indicators)
Number of subjects: 2859
Study 31176057 — intervention group
Group type: EXPERIMENTAL
Intervention: Agency regarding attitudes about gender norms
Number of subjects: 2859
Study 31176057 — intervention group
Group type: EXPERIMENTAL
Intervention: Agency regarding speaking up in public
Number of subjects: 2859
Study 29654643 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin 0 mg (placebo)
Number of subjects: 8
Study 29654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 25 mg
Number of subjects: 8
Study 29654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 8
Study 29654643 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 200 mg
Number of subjects: 8
Study 27068582 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative patient-controlled intravenous analgesia
Number of subjects: 370
Study 27068582 — intervention group
Group type: COMPARATOR
Intervention: Postoperative epidural analgesia
Number of subjects: 370
Study 24304349 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of daily supervised consumption of OMT
Number of subjects: 293
Study 24304349 — intervention group
Group type: COMPARATOR
Intervention: 1 month or less of daily supervised OMT, then daily unsupervised consumption
Number of subjects: 293
Study 24304349 — intervention group
Group type: COMPARATOR
Intervention: 1 month or less of daily unsupervised consumption
Number of subjects: 293
Study 22265975 — intervention group
Group type: COMPARATOR
Intervention: Higher placebo adherence (≥75% adherence)
Number of subjects: 0
Study 22265975 — intervention group
Group type: COMPARATOR
Intervention: Lower placebo adherence (<75% adherence)
Number of subjects: 0
Study 19174306 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine
Number of subjects: 0
Study 19174306 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside
Number of subjects: 0
Study 19174306 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 0
Study 19174306 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study 17587087 — intervention group
Group type: EXPERIMENTAL
Intervention: Starion hemorrhoidectomy
Number of subjects: 64
Study 17587087 — intervention group
Group type: COMPARATOR
Intervention: Ligasure hemorrhoidectomy
Number of subjects: 64
Study 15253170 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal therapeutic system fentanyl (TTS-F)
Number of subjects: 0
Study 12435175 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine and docetaxel combination treatment
Number of subjects: 0
Study 12435175 — intervention group
Group type: COMPARATOR
Intervention: Single-agent docetaxel
Number of subjects: 0
Study 12435175 — intervention group
Group type: EXPERIMENTAL
Intervention: Poststudy treatment with capecitabine
Number of subjects: 0
Study 12435175 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (capecitabine/docetaxel)
Number of subjects: 0
Study 9825366 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic therapy
Number of subjects: 32
Study 9825366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 8110697 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release acetazolamide (500 mg twice a day)
Number of subjects: 30
Study 8110697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2114627 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant IFN‐gamma (100 micrograms each)
Number of subjects: 30
Study 2114627 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 113143 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 mg orally followed by TRH intravenously
Number of subjects: 6
Study 113143 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 mg orally followed by placebo injection
Number of subjects: 6
Study 113143 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet followed by TRH intravenously
Number of subjects: 6
Study 113143 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet followed by placebo injection
Number of subjects: 6
Study 31229376 — intervention group
Group type: EXPERIMENTAL
Intervention: HREZ (HRE + Pyrazinamide)
Number of subjects: 89
Study 31229376 — intervention group
Group type: COMPARATOR
Intervention: HRE (Isoniazid, Rifampicin, Ethambutol)
Number of subjects: 89
Study 27834619 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose plyometric training (PT), 60 foot contacts, twice-weekly for 6 weeks
Number of subjects: 38
Study 27834619 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 27834619 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose plyometric training (PT) in Mid-PHV group
Number of subjects: 38
Study 27834619 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose plyometric training (PT) in Pre-PHV group
Number of subjects: 38
Study 25576320 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro fertilisation with single embryo transfer
Number of subjects: 602
Study 25576320 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro fertilisation in a modified natural cycle
Number of subjects: 602
Study 25576320 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine insemination with controlled ovarian hyperstimulation
Number of subjects: 602
Study 23470915 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training + normal heat (ET+NH)
Number of subjects: 45
Study 23470915 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training + moderate heat (ET+MH)
Number of subjects: 45
Study 23470915 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training + normal heat (WT+NH)
Number of subjects: 45
Study 23470915 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training + moderate heat (WT+MH)
Number of subjects: 45
Study 23470915 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat group (HG)
Number of subjects: 45
Study 20623240 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundus-down laparoscopic cholecystectomy
Number of subjects: 64
Study 20623240 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy
Number of subjects: 64
Study 19443665 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimney woodstove (plancha)
Number of subjects: 504
Study 19443665 — intervention group
Group type: COMPARATOR
Intervention: Open fire (control)
Number of subjects: 504